Current Neuropharmacology
Title:Meet Our Editorial Board Member
Volume: 17 Issue: 1
Author(s): Francesca Fallarino
Affiliation:
Export Options
About this article
Cite this article as:
Fallarino Francesca , Meet Our Editorial Board Member, Current Neuropharmacology 2019; 17 (1) . https://dx.doi.org/10.2174/1570159X1701181129110842
DOI https://dx.doi.org/10.2174/1570159X1701181129110842 |
Print ISSN 1570-159X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6190 |
22
1
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Use of Herbal Medicine in Cancer-related Anorexia/ Cachexia Treatment Around the World
Current Pharmaceutical Design Molecular Mechanisms Underlying the Dedifferentiation Process of Isolated Hepatocytes and Their Cultures
Current Drug Metabolism Patents on Immunotoxins and Chimeric Toxins for the Treatment of Cancer
Recent Patents on Drug Delivery & Formulation Resilience Dysregulation in Major Depressive Disorder: Focus on Glutamatergic Imbalance and Microglial Activation
Current Neuropharmacology A Novel Approach to Inhibit Heat Shock Response as Anticancer Strategy by Coumarine Compounds Containing Thiazole Skeleton
Anti-Cancer Agents in Medicinal Chemistry Predicted Mechanism of Antiasthmatic Drugs in Depression Based on Their Interaction with SERT and 5-HT1A Receptors
Current Enzyme Inhibition Reactive Astrogliosis: Role in Alzheimer's Disease
CNS & Neurological Disorders - Drug Targets Editorial [Hot topic: The Urokinase Receptor System as Strategic Therapeutic Target: Challenges for the 21st Century (Executive Guest Editor: Bernard Degryse)]
Current Pharmaceutical Design Cyclic Nucleotide Phosphodiesterases (PDE) and Peptide Motifs
Current Pharmaceutical Design Layered Double Hydroxides as Flame Retardant and Thermal Stabilizer for Polymers
Recent Patents on Nanotechnology Pyrimidine Derivatives as Potential Agents Acting on Central Nervous System
Central Nervous System Agents in Medicinal Chemistry The Molecular Basis of Conantokin Antagonism of NMDA Receptor Function
Current Drug Targets Cardiovascular and Renovascular Implications of COX-2 Inhibition
Current Pharmaceutical Design Rho-kinase (ROCK) Inhibitors - A Neuroprotective Therapeutic Paradigm with a Focus on Ocular Utility
Current Medicinal Chemistry Wnt Signalling is a Relevant Pathway Contributing to Amyloid Beta-Peptide-Mediated Neuropathology in Alzheimers Disease
CNS & Neurological Disorders - Drug Targets Inhibitors of Monoamine Oxidase and Acetylcholinesterase as a Front Runner in CNS Drug Discovery
Combinatorial Chemistry & High Throughput Screening Narcolepsy in Adolescents: A Review and Three Case Reports
Adolescent Psychiatry Headache, Outpatient Management and Referral to Specialty Clinics, Clinical Audit
New Emirates Medical Journal In Silico Methods to Assist Drug Developers in Acetylcholinesterase Inhibitor Design
Current Medicinal Chemistry An Update on “Selenium Containing Compounds from Poison to Drug Candidates: A Review on the GPx-like Activity”
Current Chemical Biology